On 4 Aug 2015, CFDA released the results from a campaign of riron ferrous fumarate 300 mgandom inspections conducted on infant formula products sold on the Chinese markferrous gluconate 695mget during May to June. 42are ferrous sulfate and ferrous gluconate the same batches all made by domestic SMEs were found to be nferro f tabon-complaint with national standards. Later on the 6th Aug, CFDA reported another two local brands detected with enterobacter sakazakii, a substance which poses a high risk to infant health and is not permitted in IF products. The companies in enfamil ferrous sulfatequestion have been ordered to recall unqualified products and cease production until problems are resolved. However these revelations are particularly concerning given the fact these manufacturers have recently been audited and approved under series of Chinese infant formula manufacturing standard reforms.
China’s Domestic Infant Formula Falls Short Again
